In IBD or immune-driven colitis the upregulation of claudin-2 can be attributed, at least partially, to the increased levels of several proinflammatory cyotkines, such as IL13 (Heller et al., 2005). This evidence concerns the gene IL13 and inflammatory bowel disease.